{"id":354374,"date":"2025-08-28T12:02:05","date_gmt":"2025-08-28T12:02:05","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-cellectis-sa\/"},"modified":"2025-08-28T12:02:05","modified_gmt":"2025-08-28T12:02:05","slug":"how-to-buy-cellectis-sa","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-354374","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Cellectis S.A. (CLLS) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Cellectis S.A. (CLLS)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Cellectis S.A. (CLLS) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Cellectis S.A. (CLLS)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed5i m\u1edbi n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng v\u00e0 c\u00e1c chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 th\u00f4ng minh cho n\u0103m 2025.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed5i m\u1edbi n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng v\u00e0 c\u00e1c chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 th\u00f4ng minh cho n\u0103m 2025."},"intro":"H\u00e3y t\u01b0\u1edfng t\u01b0\u1ee3ng s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n t\u01b0\u01a1ng lai c\u1ee7a \u0111i\u1ec1u tr\u1ecb ung th\u01b0. Cellectis kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u00f4ng th\u01b0\u1eddng \u2014 h\u1ecd \u0111ang ti\u00ean phong trong li\u1ec7u ph\u00e1p CAR-T s\u1eb5n c\u00f3 c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh ung th\u01b0 m\u00e1u. C\u1ed5 phi\u1ebfu c\u1ee7a h\u1ecd mang l\u1ea1i ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng b\u00f9ng n\u1ed5 c\u00f9ng v\u1edbi s\u1ef1 h\u00e0i l\u00f2ng khi h\u1ed7 tr\u1ee3 \u0111\u1ed5i m\u1edbi y t\u1ebf c\u1ee9u s\u1ed1ng con ng\u01b0\u1eddi.","intro_source":{"label":"Intro","type":"text","formatted_value":"H\u00e3y t\u01b0\u1edfng t\u01b0\u1ee3ng s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n t\u01b0\u01a1ng lai c\u1ee7a \u0111i\u1ec1u tr\u1ecb ung th\u01b0. Cellectis kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u00f4ng th\u01b0\u1eddng \u2014 h\u1ecd \u0111ang ti\u00ean phong trong li\u1ec7u ph\u00e1p CAR-T s\u1eb5n c\u00f3 c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh ung th\u01b0 m\u00e1u. C\u1ed5 phi\u1ebfu c\u1ee7a h\u1ecd mang l\u1ea1i ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng b\u00f9ng n\u1ed5 c\u00f9ng v\u1edbi s\u1ef1 h\u00e0i l\u00f2ng khi h\u1ed7 tr\u1ee3 \u0111\u1ed5i m\u1edbi y t\u1ebf c\u1ee9u s\u1ed1ng con ng\u01b0\u1eddi."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Cellectis: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 28 th\u00e1ng 8 n\u0103m 2025, Cellectis S.A. (CLLS) giao d\u1ecbch \u1edf m\u1ee9c <strong>2,59 USD<\/strong> tr\u00ean s\u00e0n NASDAQ. Nh\u01b0ng \u0111i\u1ec1u th\u1ef1c s\u1ef1 quan tr\u1ecdng l\u00e0: <strong>ng\u00e0y 3 th\u00e1ng 11 n\u0103m 2025<\/strong> c\u00f3 th\u1ec3 l\u00e0 b\u01b0\u1edbc ngo\u1eb7t. \u0110\u00f3 l\u00e0 khi c\u00f4ng ty c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3, v\u00e0 n\u1ebfu l\u1ecbch s\u1eed l\u1eb7p l\u1ea1i, ch\u00fang ta c\u00f3 th\u1ec3 ch\u1ee9ng ki\u1ebfn bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p> <p><strong>T\u1ea1i sao ng\u00e0y 3 th\u00e1ng 11 quan tr\u1ecdng:<\/strong><br\/> B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn g\u1ea7n nh\u1ea5t v\u00e0o ng\u00e0y 4 th\u00e1ng 8 n\u0103m 2025 cho th\u1ea5y doanh thu t\u0103ng g\u1ea5p \u0111\u00f4i l\u00ean 12 tri\u1ec7u USD t\u1eeb 6,5 tri\u1ec7u USD trong qu\u00fd 1 n\u0103m 2024. M\u1eb7c d\u00f9 c\u1ed5 phi\u1ebfu ban \u0111\u1ea7u gi\u1ea3m nh\u1eb9 sau th\u00f4ng b\u00e1o, n\u00f3 nhanh ch\u00f3ng ph\u1ee5c h\u1ed3i khi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 ti\u1ebfp nh\u1eadn v\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t m\u1ea1nh m\u1ebd 246 tri\u1ec7u USD v\u00e0 c\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u00e2m s\u00e0ng s\u1eafp t\u1edbi.<\/p> <p><strong>M\u1eabu h\u00ecnh t\u00e1c \u0111\u1ed9ng l\u1ee3i nhu\u1eadn g\u1ea7n \u0111\u00e2y:<\/strong><\/p> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc<\/th><th>Gi\u00e1 Sau<\/th><th>Thay \u0110\u1ed5i<\/th><\/tr> <\/thead> <tbody> <tr><td>4 th\u00e1ng 8, 2025<\/td><td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td><td>2,70 USD<\/td><td>2,65 USD<\/td><td>-1,9%<\/td><\/tr> <tr><td>Th\u00e1ng 5, 2025<\/td><td>L\u1ee3i nhu\u1eadn qu\u00fd 1<\/td><td>1,84 USD<\/td><td>2,15 USD<\/td><td>+16,8%<\/td><\/tr> <tr><td>Th\u00e1ng 3, 2025<\/td><td>K\u1ebft qu\u1ea3 n\u0103m t\u00e0i ch\u00ednh 2024<\/td><td>1,50 USD<\/td><td>1,75 USD<\/td><td>+16,7%<\/td><\/tr> <\/tbody> <\/table> <p>M\u1eabu h\u00ecnh cho th\u1ea5y s\u1ef1 bi\u1ebfn \u0111\u1ed9ng ban \u0111\u1ea7u theo sau l\u00e0 t\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng khi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 x\u1eed l\u00fd ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng \u0111\u1eb1ng sau c\u00e1c con s\u1ed1.<\/p>  [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u1eeb Kh\u00f3 Kh\u0103n \u0110\u1ebfn B\u1ee9t Ph\u00e1<\/h2> <p>Cellectis \u0111\u00e3 tr\u1ea3i qua m\u1ed9t chuy\u1ebfn t\u00e0u l\u01b0\u1ee3n si\u00eau t\u1ed1c! Trong 6 th\u00e1ng qua, c\u1ed5 phi\u1ebfu \u0111\u00e3 mang l\u1ea1i l\u1ee3i nhu\u1eadn \u1ea5n t\u01b0\u1ee3ng <strong>87,5%<\/strong>, v\u01b0\u1ee3t xa m\u1ee9c t\u0103ng +11% c\u1ee7a S&P 500 trong c\u00f9ng k\u1ef3.<\/p> <p><strong>Ph\u00e2n t\u00edch theo th\u00e1ng:<\/strong><\/p> <ul> <li><strong>Th\u00e1ng 3, 2025<\/strong>: 1,50 USD (\u0111\u00e0 sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn)<\/li> <li><strong>Th\u00e1ng 4, 2025<\/strong>: 1,75 USD (t\u0103ng nh\u1edd ph\u00ea duy\u1ec7t \u0111\u1eb7t t\u00ean c\u1ee7a WHO)<\/li> <li><strong>Th\u00e1ng 5, 2025<\/strong>: 2,15 USD (v\u01b0\u1ee3t k\u1ef3 v\u1ecdng l\u1ee3i nhu\u1eadn qu\u00fd 1)<\/li> <li><strong>Th\u00e1ng 6, 2025<\/strong>: 2,40 USD (mong \u0111\u1ee3i cu\u1ed9c h\u1ecdp FDA)<\/li> <li><strong>Th\u00e1ng 7, 2025<\/strong>: 2,65 USD (th\u00e0nh c\u00f4ng trong c\u00e1c cu\u1ed9c h\u1ecdp FDA\/EMA)<\/li> <li><strong>Th\u00e1ng 8, 2025<\/strong>: 2,59 USD (\u0111i\u1ec1u ch\u1ec9nh hi\u1ec7n t\u1ea1i)<\/li> <\/ul> <p>C\u1ed5 phi\u1ebfu \u0111\u00e3 ch\u1ea1m \u0111\u00e1y 52 tu\u1ea7n \u1edf m\u1ee9c 1,10 USD \u0111\u1ea7u n\u0103m 2025 v\u00e0 k\u1ec3 t\u1eeb \u0111\u00f3 \u0111\u00e3 t\u0103ng l\u00ean g\u1ea7n m\u1ee9c cao 52 tu\u1ea7n l\u00e0 3,24 USD, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng ph\u1ee5c h\u1ed3i 195% t\u1eeb \u0111\u00e1y.<\/p>  <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p><strong>G\u1ea7n h\u1ea1n (2025)<\/strong>: D\u1ef1 ki\u1ebfn bi\u1ebfn \u0111\u1ed9ng quanh ng\u00e0y 3 th\u00e1ng 11, nh\u01b0ng ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt cho th\u1ea5y kh\u1ea3 n\u0103ng t\u0103ng l\u00ean <strong>3,50-4,00 USD<\/strong> v\u00e0o cu\u1ed1i n\u0103m khi b\u1eaft \u0111\u1ea7u th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 2 cung c\u1ea5p s\u1ef1 x\u00e1c nh\u1eadn.<\/p> <p><strong>D\u1ef1 b\u00e1o 2026<\/strong>: V\u1edbi d\u1eef li\u1ec7u giai \u0111o\u1ea1n 2 d\u1ef1 ki\u1ebfn v\u00e0 kh\u1ea3 n\u0103ng m\u1edf r\u1ed9ng h\u1ee3p t\u00e1c, CLLS c\u00f3 th\u1ec3 \u0111\u1ea1t m\u1ee9c <strong>6-8 USD<\/strong> n\u1ebfu k\u1ebft qu\u1ea3 l\u00e2m s\u00e0ng t\u00edch c\u1ef1c.<\/p> <p><strong>D\u1ef1 \u0111o\u00e1n 2028<\/strong>: N\u1ebfu lasme-cel \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i, c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 giao d\u1ecbch trong kho\u1ea3ng <strong>12-15 USD<\/strong> d\u1ef1a tr\u00ean \u01b0\u1edbc t\u00ednh doanh s\u1ed1 \u0111\u1ec9nh \u0111i\u1ec3m.<\/p> <p><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: M\u00f4 h\u00ecnh d\u00e0i h\u1ea1n cho th\u1ea5y m\u1ee5c ti\u00eau <strong>16,30 USD<\/strong>, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng l\u1ee3i nhu\u1eadn ti\u1ec1m n\u0103ng 530% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i n\u1ebfu th\u1ef1c thi t\u1ed1t.<\/p> <p><strong>K\u1ebft lu\u1eadn<\/strong>: MUA cho nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro v\u1edbi t\u1ea7m nh\u00ecn 3-5 n\u0103m. C\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u00e2m s\u00e0ng v\u00e0 doanh thu h\u1ee3p t\u00e1c cung c\u1ea5p nhi\u1ec1u con \u0111\u01b0\u1eddng d\u1eabn \u0111\u1ebfn th\u00e0nh c\u00f4ng.<\/p>  <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <p><strong>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc:<\/strong><\/p> <ul> <li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc s\u1ed1ng ch\u1ebft d\u1ef1a v\u00e0o d\u1eef li\u1ec7u l\u00e2m s\u00e0ng \u2014 k\u1ebft qu\u1ea3 ti\u00eau c\u1ef1c c\u00f3 th\u1ec3 x\u00f3a s\u1ea1ch l\u1ee3i nhu\u1eadn nhanh ch\u00f3ng<\/li> <li><strong>Ti\u00eau ti\u1ec1n m\u1eb7t<\/strong>: L\u1ed7 18 tri\u1ec7u USD m\u1ed7i qu\u00fd m\u1eb7c d\u00f9 doanh thu t\u0103ng l\u00e0m d\u1ea5y l\u00ean lo ng\u1ea1i v\u1ec1 t\u00ednh b\u1ec1n v\u1eefng<\/li> <li><strong>R\u00e0o c\u1ea3n ph\u00e1p l\u00fd<\/strong>: Ph\u00ea duy\u1ec7t FDA kh\u00f4ng bao gi\u1edd ch\u1eafc ch\u1eafn, \u0111\u1eb7c bi\u1ec7t v\u1edbi li\u1ec7u ph\u00e1p m\u1edbi<\/li> <li><strong>Bi\u1ebfn \u0111\u1ed9ng<\/strong>: Bi\u1ebfn \u0111\u1ed9ng h\u00e0ng ng\u00e0y 14,35% g\u00e2y dao \u0111\u1ed9ng gi\u00e1 m\u1ea1nh<\/li> <li><strong>Ph\u1ee5 thu\u1ed9c \u0111\u1ed1i t\u00e1c<\/strong>: 57% doanh thu t\u1eeb AstraZeneca t\u1ea1o r\u1ee7i ro t\u1eadp trung<\/li> <\/ul> <p><strong>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho 2025:<\/strong><\/p> <ul> <li>\u2705 C\u00e1c cu\u1ed9c h\u1ecdp FDA\/EMA ho\u00e0n th\u00e0nh th\u00e0nh c\u00f4ng v\u00e0o th\u00e1ng 7 n\u0103m 2025<\/li> <li>\u2705 B\u1eaft \u0111\u1ea7u th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 2 d\u1ef1 ki\u1ebfn n\u1eeda cu\u1ed1i 2025<\/li> <li>\u2705 D\u00f2ng ti\u1ec1n 246 tri\u1ec7u USD \u0111\u1ee7 d\u00f9ng \u0111\u1ebfn n\u0103m 2027<\/li> <li>\u2705 H\u1ee3p t\u00e1c v\u1edbi AstraZeneca t\u1ea1o doanh thu \u1ed5n \u0111\u1ecbnh<\/li> <li>\u2705 T\u00ean g\u1ecdi ch\u00ednh th\u1ee9c c\u1ee7a WHO x\u00e1c nh\u1eadn ti\u1ebfn tri\u1ec3n ph\u00e1p l\u00fd<\/li> <li>\u2705 Ng\u00e0y R&D cho nh\u00e0 \u0111\u1ea7u t\u01b0 16 th\u00e1ng 10 n\u0103m 2025 c\u00f3 th\u1ec3 l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 5% danh m\u1ee5c cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao nh\u01b0 CLLS<\/li> <li><strong>Trung b\u00ecnh gi\u00e1<\/strong>: Mua t\u1eebng ph\u1ea7n thay v\u00ec m\u1ed9t l\u1ea7n \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro th\u1eddi \u0111i\u1ec3m<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o ng\u00e0y 3 th\u00e1ng 11<\/strong>: L\u1ee3i nhu\u1eadn c\u00f3 th\u1ec3 t\u1ea1o \u0111i\u1ec3m v\u00e0o t\u1ed1t h\u01a1n n\u1ebfu c\u1ed5 phi\u1ebfu gi\u1ea3m<\/li> <li><strong>Theo d\u00f5i c\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u00e2m s\u00e0ng<\/strong>: Ng\u00e0y R&D th\u00e1ng 10 v\u00e0 b\u1eaft \u0111\u1ea7u giai \u0111o\u1ea1n 2 l\u00e0 c\u00e1c s\u1ef1 ki\u1ec7n quan tr\u1ecdng<\/li> <li><strong>Ki\u1ec3m tra th\u1ef1c t\u1ebf h\u00e0i h\u01b0\u1edbc<\/strong>: \"Giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc gi\u1ed1ng nh\u01b0 ph\u1eabu thu\u1eadt tim \u2014 h\u1ed3i h\u1ed9p khi th\u00e0nh c\u00f4ng, th\u1ea3m h\u1ecda khi th\u1ea5t b\u1ea1i. C\u00f3 th\u1ec3 n\u00ean luy\u1ec7n t\u1eadp tr\u00ean gi\u1ea5y tr\u01b0\u1edbc!\"<\/li> <\/ol>  <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Cellectis S.A. (CLLS) - T\u1eebng B\u01b0\u1edbc<\/h2> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o c\u00f3 c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft NASDAQ v\u00e0 ph\u00ed h\u1ee3p l\u00fd<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n t\u1ea5t n\u1ea1p ti\u1ec1n t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n s\u1eb5n s\u00e0ng c\u00f3 th\u1ec3 m\u1ea5t<\/td><\/tr> <tr><td>3<\/td><td>T\u00ecm ki\u1ebfm \"CLLS\"<\/td><td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td><\/tr> <tr><td>4<\/td><td>\u0110\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n<\/td><td>Tr\u00e1nh l\u1ec7nh th\u1ecb tr\u01b0\u1eddng \u2014 \u0111\u1eb7t gi\u00e1 mua t\u1ed1i \u0111a c\u1ee7a b\u1ea1n<\/td><\/tr> <tr><td>5<\/td><td>Xem l\u1ea1i chi ti\u1ebft l\u1ec7nh<\/td><td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng v\u00e0 ng\u00e0y thanh to\u00e1n<\/td><\/tr> <tr><td>6<\/td><td>Th\u1ef1c hi\u1ec7n mua<\/td><td>X\u00e1c nh\u1eadn v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf<\/td><\/tr> <tr><td>7<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/td><td>Theo d\u00f5i c\u00e1c m\u1ee9c quan tr\u1ecdng nh\u01b0 3,24 USD (cao nh\u1ea5t 52 tu\u1ea7n)<\/td><\/tr> <tr><td>8<\/td><td>L\u1eadp k\u1ebf ho\u1ea1ch tho\u00e1t<\/td><td>Quy\u1ebft \u0111\u1ecbnh m\u1ee9c ch\u1ed1t l\u1eddi v\u00e0 c\u1eaft l\u1ed7 tr\u01b0\u1edbc<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf gi\u00fap vi\u1ec7c tham gia th\u1ecb tr\u01b0\u1eddng ch\u1ee9ng kho\u00e1n b\u1edbt \u0111\u00e1ng s\u1ee3:<\/p> <ul> <li><strong>Ti\u1ec1n g\u1eedi t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> - B\u1ea1n c\u00f3 th\u1ec3 th\u1eed chi\u1ebfn l\u01b0\u1ee3c v\u1edbi ti\u1ec1n th\u1eadt m\u00e0 kh\u00f4ng c\u1ea7n cam k\u1ebft t\u00e0i ch\u00ednh l\u1edbn<\/li> <li><strong>X\u00e1c minh nhanh nh\u01b0 ch\u1edbp<\/strong> - T\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch trong v\u00e0i ph\u00fat, kh\u00f4ng ph\u1ea3i v\u00e0i ng\u00e0y<\/li> <li><strong>Nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> - Truy c\u1eadp l\u1ee3i nhu\u1eadn qua h\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng<\/li> <\/ul> <p>Giao di\u1ec7n th\u00e2n thi\u1ec7n c\u1ee7a n\u1ec1n t\u1ea3ng gi\u00fap theo d\u00f5i v\u1ecb th\u1ebf nh\u01b0 CLLS d\u1ec5 d\u00e0ng, trong khi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p cho ph\u00e9p b\u1ea1n t\u00edch l\u0169y kinh nghi\u1ec7m th\u1ef1c t\u1ebf v\u1edbi c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc m\u00e0 kh\u00f4ng l\u00e0m qu\u00e1 t\u1ea3i danh m\u1ee5c \u0111\u1ea7u t\u01b0.<\/p>  <h2>\ud83c\udf0d Cellectis N\u0103m 2025: Ti\u00ean Phong Ch\u1ec9nh S\u1eeda Gen<\/h2> <p>Cellectis \u0111\u1ee9ng \u1edf tuy\u1ebfn \u0111\u1ea7u \u0111\u1ed5i m\u1edbi y t\u1ebf v\u1edbi n\u1ec1n t\u1ea3ng c\u00f4ng ngh\u1ec7 ch\u1ec9nh s\u1eeda gen TALEN\u00ae. C\u00f4ng ty ph\u00e1t tri\u1ec3n li\u1ec7u ph\u00e1p CAR-T d\u1ecb \u1ee9ng \u2014 v\u1ec1 c\u01a1 b\u1ea3n l\u00e0 c\u00e1c li\u1ec7u ph\u00e1p ung th\u01b0 \"s\u1eb5n c\u00f3\" kh\u00f4ng c\u1ea7n s\u1ea3n xu\u1ea5t t\u00f9y ch\u1ec9nh cho t\u1eebng b\u1ec7nh nh\u00e2n.<\/p> <p><strong>V\u1ecb tr\u00ed th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i<\/strong>: V\u1edbi h\u01a1n 300 b\u1eb1ng s\u00e1ng ch\u1ebf \u0111\u01b0\u1ee3c c\u1ea5p v\u00e0 c\u00e1c h\u1ee3p t\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn, Cellectis \u0111\u00e3 t\u1ea1o ra m\u1ed9t h\u00e0o b\u1ea3o v\u1ec7 s\u1edf h\u1eefu tr\u00ed tu\u1ec7 v\u1eefng ch\u1eafc quanh c\u00f4ng ngh\u1ec7 c\u1ee7a h\u1ecd.<\/p> <p><strong>S\u1ef1 ki\u1ec7n th\u00fa v\u1ecb n\u0103m 2025<\/strong>: T\u1ed5 ch\u1ee9c Y t\u1ebf Th\u1ebf gi\u1edbi \u0111\u00e3 \u0111\u1eb7t t\u00ean \"lasmecabtagene timgedleucel\" cho \u1ee9ng vi\u00ean h\u00e0ng \u0111\u1ea7u UCART22 c\u1ee7a h\u1ecd v\u00e0o th\u00e1ng 4 n\u0103m 2025 \u2014 m\u1ed9t c\u1ed9t m\u1ed1c ph\u00e1p l\u00fd quan tr\u1ecdng th\u01b0\u1eddng \u0111i tr\u01b0\u1edbc c\u00e1c ph\u00ea duy\u1ec7t thu\u1ed1c th\u00e0nh c\u00f4ng. Vi\u1ec7c ph\u00ea duy\u1ec7t t\u00ean g\u1ecdi n\u00e0y cho th\u1ea5y c\u00e1c c\u01a1 quan y t\u1ebf to\u00e0n c\u1ea7u c\u00f4ng nh\u1eadn t\u1ea7m quan tr\u1ecdng ti\u1ec1m n\u0103ng c\u1ee7a li\u1ec7u ph\u00e1p trong \u0111i\u1ec1u tr\u1ecb ung th\u01b0 m\u00e1u.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Cellectis: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 28 th\u00e1ng 8 n\u0103m 2025, Cellectis S.A. (CLLS) giao d\u1ecbch \u1edf m\u1ee9c <strong>2,59 USD<\/strong> tr\u00ean s\u00e0n NASDAQ. Nh\u01b0ng \u0111i\u1ec1u th\u1ef1c s\u1ef1 quan tr\u1ecdng l\u00e0: <strong>ng\u00e0y 3 th\u00e1ng 11 n\u0103m 2025<\/strong> c\u00f3 th\u1ec3 l\u00e0 b\u01b0\u1edbc ngo\u1eb7t. \u0110\u00f3 l\u00e0 khi c\u00f4ng ty c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3, v\u00e0 n\u1ebfu l\u1ecbch s\u1eed l\u1eb7p l\u1ea1i, ch\u00fang ta c\u00f3 th\u1ec3 ch\u1ee9ng ki\u1ebfn bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p>\n<p><strong>T\u1ea1i sao ng\u00e0y 3 th\u00e1ng 11 quan tr\u1ecdng:<\/strong><br \/> B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn g\u1ea7n nh\u1ea5t v\u00e0o ng\u00e0y 4 th\u00e1ng 8 n\u0103m 2025 cho th\u1ea5y doanh thu t\u0103ng g\u1ea5p \u0111\u00f4i l\u00ean 12 tri\u1ec7u USD t\u1eeb 6,5 tri\u1ec7u USD trong qu\u00fd 1 n\u0103m 2024. M\u1eb7c d\u00f9 c\u1ed5 phi\u1ebfu ban \u0111\u1ea7u gi\u1ea3m nh\u1eb9 sau th\u00f4ng b\u00e1o, n\u00f3 nhanh ch\u00f3ng ph\u1ee5c h\u1ed3i khi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 ti\u1ebfp nh\u1eadn v\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t m\u1ea1nh m\u1ebd 246 tri\u1ec7u USD v\u00e0 c\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u00e2m s\u00e0ng s\u1eafp t\u1edbi.<\/p>\n<p><strong>M\u1eabu h\u00ecnh t\u00e1c \u0111\u1ed9ng l\u1ee3i nhu\u1eadn g\u1ea7n \u0111\u00e2y:<\/strong><\/p>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc<\/th>\n<th>Gi\u00e1 Sau<\/th>\n<th>Thay \u0110\u1ed5i<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>4 th\u00e1ng 8, 2025<\/td>\n<td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td>\n<td>2,70 USD<\/td>\n<td>2,65 USD<\/td>\n<td>-1,9%<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 5, 2025<\/td>\n<td>L\u1ee3i nhu\u1eadn qu\u00fd 1<\/td>\n<td>1,84 USD<\/td>\n<td>2,15 USD<\/td>\n<td>+16,8%<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 3, 2025<\/td>\n<td>K\u1ebft qu\u1ea3 n\u0103m t\u00e0i ch\u00ednh 2024<\/td>\n<td>1,50 USD<\/td>\n<td>1,75 USD<\/td>\n<td>+16,7%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>M\u1eabu h\u00ecnh cho th\u1ea5y s\u1ef1 bi\u1ebfn \u0111\u1ed9ng ban \u0111\u1ea7u theo sau l\u00e0 t\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng khi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 x\u1eed l\u00fd ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng \u0111\u1eb1ng sau c\u00e1c con s\u1ed1.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u1eeb Kh\u00f3 Kh\u0103n \u0110\u1ebfn B\u1ee9t Ph\u00e1<\/h2>\n<p>Cellectis \u0111\u00e3 tr\u1ea3i qua m\u1ed9t chuy\u1ebfn t\u00e0u l\u01b0\u1ee3n si\u00eau t\u1ed1c! Trong 6 th\u00e1ng qua, c\u1ed5 phi\u1ebfu \u0111\u00e3 mang l\u1ea1i l\u1ee3i nhu\u1eadn \u1ea5n t\u01b0\u1ee3ng <strong>87,5%<\/strong>, v\u01b0\u1ee3t xa m\u1ee9c t\u0103ng +11% c\u1ee7a S&#038;P 500 trong c\u00f9ng k\u1ef3.<\/p>\n<p><strong>Ph\u00e2n t\u00edch theo th\u00e1ng:<\/strong><\/p>\n<ul>\n<li><strong>Th\u00e1ng 3, 2025<\/strong>: 1,50 USD (\u0111\u00e0 sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn)<\/li>\n<li><strong>Th\u00e1ng 4, 2025<\/strong>: 1,75 USD (t\u0103ng nh\u1edd ph\u00ea duy\u1ec7t \u0111\u1eb7t t\u00ean c\u1ee7a WHO)<\/li>\n<li><strong>Th\u00e1ng 5, 2025<\/strong>: 2,15 USD (v\u01b0\u1ee3t k\u1ef3 v\u1ecdng l\u1ee3i nhu\u1eadn qu\u00fd 1)<\/li>\n<li><strong>Th\u00e1ng 6, 2025<\/strong>: 2,40 USD (mong \u0111\u1ee3i cu\u1ed9c h\u1ecdp FDA)<\/li>\n<li><strong>Th\u00e1ng 7, 2025<\/strong>: 2,65 USD (th\u00e0nh c\u00f4ng trong c\u00e1c cu\u1ed9c h\u1ecdp FDA\/EMA)<\/li>\n<li><strong>Th\u00e1ng 8, 2025<\/strong>: 2,59 USD (\u0111i\u1ec1u ch\u1ec9nh hi\u1ec7n t\u1ea1i)<\/li>\n<\/ul>\n<p>C\u1ed5 phi\u1ebfu \u0111\u00e3 ch\u1ea1m \u0111\u00e1y 52 tu\u1ea7n \u1edf m\u1ee9c 1,10 USD \u0111\u1ea7u n\u0103m 2025 v\u00e0 k\u1ec3 t\u1eeb \u0111\u00f3 \u0111\u00e3 t\u0103ng l\u00ean g\u1ea7n m\u1ee9c cao 52 tu\u1ea7n l\u00e0 3,24 USD, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng ph\u1ee5c h\u1ed3i 195% t\u1eeb \u0111\u00e1y.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p><strong>G\u1ea7n h\u1ea1n (2025)<\/strong>: D\u1ef1 ki\u1ebfn bi\u1ebfn \u0111\u1ed9ng quanh ng\u00e0y 3 th\u00e1ng 11, nh\u01b0ng ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt cho th\u1ea5y kh\u1ea3 n\u0103ng t\u0103ng l\u00ean <strong>3,50-4,00 USD<\/strong> v\u00e0o cu\u1ed1i n\u0103m khi b\u1eaft \u0111\u1ea7u th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 2 cung c\u1ea5p s\u1ef1 x\u00e1c nh\u1eadn.<\/p>\n<p><strong>D\u1ef1 b\u00e1o 2026<\/strong>: V\u1edbi d\u1eef li\u1ec7u giai \u0111o\u1ea1n 2 d\u1ef1 ki\u1ebfn v\u00e0 kh\u1ea3 n\u0103ng m\u1edf r\u1ed9ng h\u1ee3p t\u00e1c, CLLS c\u00f3 th\u1ec3 \u0111\u1ea1t m\u1ee9c <strong>6-8 USD<\/strong> n\u1ebfu k\u1ebft qu\u1ea3 l\u00e2m s\u00e0ng t\u00edch c\u1ef1c.<\/p>\n<p><strong>D\u1ef1 \u0111o\u00e1n 2028<\/strong>: N\u1ebfu lasme-cel \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i, c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 giao d\u1ecbch trong kho\u1ea3ng <strong>12-15 USD<\/strong> d\u1ef1a tr\u00ean \u01b0\u1edbc t\u00ednh doanh s\u1ed1 \u0111\u1ec9nh \u0111i\u1ec3m.<\/p>\n<p><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: M\u00f4 h\u00ecnh d\u00e0i h\u1ea1n cho th\u1ea5y m\u1ee5c ti\u00eau <strong>16,30 USD<\/strong>, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng l\u1ee3i nhu\u1eadn ti\u1ec1m n\u0103ng 530% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i n\u1ebfu th\u1ef1c thi t\u1ed1t.<\/p>\n<p><strong>K\u1ebft lu\u1eadn<\/strong>: MUA cho nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro v\u1edbi t\u1ea7m nh\u00ecn 3-5 n\u0103m. C\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u00e2m s\u00e0ng v\u00e0 doanh thu h\u1ee3p t\u00e1c cung c\u1ea5p nhi\u1ec1u con \u0111\u01b0\u1eddng d\u1eabn \u0111\u1ebfn th\u00e0nh c\u00f4ng.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<p><strong>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc:<\/strong><\/p>\n<ul>\n<li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc s\u1ed1ng ch\u1ebft d\u1ef1a v\u00e0o d\u1eef li\u1ec7u l\u00e2m s\u00e0ng \u2014 k\u1ebft qu\u1ea3 ti\u00eau c\u1ef1c c\u00f3 th\u1ec3 x\u00f3a s\u1ea1ch l\u1ee3i nhu\u1eadn nhanh ch\u00f3ng<\/li>\n<li><strong>Ti\u00eau ti\u1ec1n m\u1eb7t<\/strong>: L\u1ed7 18 tri\u1ec7u USD m\u1ed7i qu\u00fd m\u1eb7c d\u00f9 doanh thu t\u0103ng l\u00e0m d\u1ea5y l\u00ean lo ng\u1ea1i v\u1ec1 t\u00ednh b\u1ec1n v\u1eefng<\/li>\n<li><strong>R\u00e0o c\u1ea3n ph\u00e1p l\u00fd<\/strong>: Ph\u00ea duy\u1ec7t FDA kh\u00f4ng bao gi\u1edd ch\u1eafc ch\u1eafn, \u0111\u1eb7c bi\u1ec7t v\u1edbi li\u1ec7u ph\u00e1p m\u1edbi<\/li>\n<li><strong>Bi\u1ebfn \u0111\u1ed9ng<\/strong>: Bi\u1ebfn \u0111\u1ed9ng h\u00e0ng ng\u00e0y 14,35% g\u00e2y dao \u0111\u1ed9ng gi\u00e1 m\u1ea1nh<\/li>\n<li><strong>Ph\u1ee5 thu\u1ed9c \u0111\u1ed1i t\u00e1c<\/strong>: 57% doanh thu t\u1eeb AstraZeneca t\u1ea1o r\u1ee7i ro t\u1eadp trung<\/li>\n<\/ul>\n<p><strong>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho 2025:<\/strong><\/p>\n<ul>\n<li>\u2705 C\u00e1c cu\u1ed9c h\u1ecdp FDA\/EMA ho\u00e0n th\u00e0nh th\u00e0nh c\u00f4ng v\u00e0o th\u00e1ng 7 n\u0103m 2025<\/li>\n<li>\u2705 B\u1eaft \u0111\u1ea7u th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 2 d\u1ef1 ki\u1ebfn n\u1eeda cu\u1ed1i 2025<\/li>\n<li>\u2705 D\u00f2ng ti\u1ec1n 246 tri\u1ec7u USD \u0111\u1ee7 d\u00f9ng \u0111\u1ebfn n\u0103m 2027<\/li>\n<li>\u2705 H\u1ee3p t\u00e1c v\u1edbi AstraZeneca t\u1ea1o doanh thu \u1ed5n \u0111\u1ecbnh<\/li>\n<li>\u2705 T\u00ean g\u1ecdi ch\u00ednh th\u1ee9c c\u1ee7a WHO x\u00e1c nh\u1eadn ti\u1ebfn tri\u1ec3n ph\u00e1p l\u00fd<\/li>\n<li>\u2705 Ng\u00e0y R&#038;D cho nh\u00e0 \u0111\u1ea7u t\u01b0 16 th\u00e1ng 10 n\u0103m 2025 c\u00f3 th\u1ec3 l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 5% danh m\u1ee5c cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao nh\u01b0 CLLS<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1<\/strong>: Mua t\u1eebng ph\u1ea7n thay v\u00ec m\u1ed9t l\u1ea7n \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro th\u1eddi \u0111i\u1ec3m<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o ng\u00e0y 3 th\u00e1ng 11<\/strong>: L\u1ee3i nhu\u1eadn c\u00f3 th\u1ec3 t\u1ea1o \u0111i\u1ec3m v\u00e0o t\u1ed1t h\u01a1n n\u1ebfu c\u1ed5 phi\u1ebfu gi\u1ea3m<\/li>\n<li><strong>Theo d\u00f5i c\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u00e2m s\u00e0ng<\/strong>: Ng\u00e0y R&#038;D th\u00e1ng 10 v\u00e0 b\u1eaft \u0111\u1ea7u giai \u0111o\u1ea1n 2 l\u00e0 c\u00e1c s\u1ef1 ki\u1ec7n quan tr\u1ecdng<\/li>\n<li><strong>Ki\u1ec3m tra th\u1ef1c t\u1ebf h\u00e0i h\u01b0\u1edbc<\/strong>: &#8220;Giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc gi\u1ed1ng nh\u01b0 ph\u1eabu thu\u1eadt tim \u2014 h\u1ed3i h\u1ed9p khi th\u00e0nh c\u00f4ng, th\u1ea3m h\u1ecda khi th\u1ea5t b\u1ea1i. C\u00f3 th\u1ec3 n\u00ean luy\u1ec7n t\u1eadp tr\u00ean gi\u1ea5y tr\u01b0\u1edbc!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Cellectis S.A. (CLLS) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o c\u00f3 c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft NASDAQ v\u00e0 ph\u00ed h\u1ee3p l\u00fd<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t n\u1ea1p ti\u1ec1n t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n s\u1eb5n s\u00e0ng c\u00f3 th\u1ec3 m\u1ea5t<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;CLLS&#8221;<\/td>\n<td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>\u0110\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n<\/td>\n<td>Tr\u00e1nh l\u1ec7nh th\u1ecb tr\u01b0\u1eddng \u2014 \u0111\u1eb7t gi\u00e1 mua t\u1ed1i \u0111a c\u1ee7a b\u1ea1n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Xem l\u1ea1i chi ti\u1ebft l\u1ec7nh<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng v\u00e0 ng\u00e0y thanh to\u00e1n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Th\u1ef1c hi\u1ec7n mua<\/td>\n<td>X\u00e1c nh\u1eadn v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/td>\n<td>Theo d\u00f5i c\u00e1c m\u1ee9c quan tr\u1ecdng nh\u01b0 3,24 USD (cao nh\u1ea5t 52 tu\u1ea7n)<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>L\u1eadp k\u1ebf ho\u1ea1ch tho\u00e1t<\/td>\n<td>Quy\u1ebft \u0111\u1ecbnh m\u1ee9c ch\u1ed1t l\u1eddi v\u00e0 c\u1eaft l\u1ed7 tr\u01b0\u1edbc<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf gi\u00fap vi\u1ec7c tham gia th\u1ecb tr\u01b0\u1eddng ch\u1ee9ng kho\u00e1n b\u1edbt \u0111\u00e1ng s\u1ee3:<\/p>\n<ul>\n<li><strong>Ti\u1ec1n g\u1eedi t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> &#8211; B\u1ea1n c\u00f3 th\u1ec3 th\u1eed chi\u1ebfn l\u01b0\u1ee3c v\u1edbi ti\u1ec1n th\u1eadt m\u00e0 kh\u00f4ng c\u1ea7n cam k\u1ebft t\u00e0i ch\u00ednh l\u1edbn<\/li>\n<li><strong>X\u00e1c minh nhanh nh\u01b0 ch\u1edbp<\/strong> &#8211; T\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch trong v\u00e0i ph\u00fat, kh\u00f4ng ph\u1ea3i v\u00e0i ng\u00e0y<\/li>\n<li><strong>Nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> &#8211; Truy c\u1eadp l\u1ee3i nhu\u1eadn qua h\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng<\/li>\n<\/ul>\n<p>Giao di\u1ec7n th\u00e2n thi\u1ec7n c\u1ee7a n\u1ec1n t\u1ea3ng gi\u00fap theo d\u00f5i v\u1ecb th\u1ebf nh\u01b0 CLLS d\u1ec5 d\u00e0ng, trong khi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p cho ph\u00e9p b\u1ea1n t\u00edch l\u0169y kinh nghi\u1ec7m th\u1ef1c t\u1ebf v\u1edbi c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc m\u00e0 kh\u00f4ng l\u00e0m qu\u00e1 t\u1ea3i danh m\u1ee5c \u0111\u1ea7u t\u01b0.<\/p>\n<h2>\ud83c\udf0d Cellectis N\u0103m 2025: Ti\u00ean Phong Ch\u1ec9nh S\u1eeda Gen<\/h2>\n<p>Cellectis \u0111\u1ee9ng \u1edf tuy\u1ebfn \u0111\u1ea7u \u0111\u1ed5i m\u1edbi y t\u1ebf v\u1edbi n\u1ec1n t\u1ea3ng c\u00f4ng ngh\u1ec7 ch\u1ec9nh s\u1eeda gen TALEN\u00ae. C\u00f4ng ty ph\u00e1t tri\u1ec3n li\u1ec7u ph\u00e1p CAR-T d\u1ecb \u1ee9ng \u2014 v\u1ec1 c\u01a1 b\u1ea3n l\u00e0 c\u00e1c li\u1ec7u ph\u00e1p ung th\u01b0 &#8220;s\u1eb5n c\u00f3&#8221; kh\u00f4ng c\u1ea7n s\u1ea3n xu\u1ea5t t\u00f9y ch\u1ec9nh cho t\u1eebng b\u1ec7nh nh\u00e2n.<\/p>\n<p><strong>V\u1ecb tr\u00ed th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i<\/strong>: V\u1edbi h\u01a1n 300 b\u1eb1ng s\u00e1ng ch\u1ebf \u0111\u01b0\u1ee3c c\u1ea5p v\u00e0 c\u00e1c h\u1ee3p t\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn, Cellectis \u0111\u00e3 t\u1ea1o ra m\u1ed9t h\u00e0o b\u1ea3o v\u1ec7 s\u1edf h\u1eefu tr\u00ed tu\u1ec7 v\u1eefng ch\u1eafc quanh c\u00f4ng ngh\u1ec7 c\u1ee7a h\u1ecd.<\/p>\n<p><strong>S\u1ef1 ki\u1ec7n th\u00fa v\u1ecb n\u0103m 2025<\/strong>: T\u1ed5 ch\u1ee9c Y t\u1ebf Th\u1ebf gi\u1edbi \u0111\u00e3 \u0111\u1eb7t t\u00ean &#8220;lasmecabtagene timgedleucel&#8221; cho \u1ee9ng vi\u00ean h\u00e0ng \u0111\u1ea7u UCART22 c\u1ee7a h\u1ecd v\u00e0o th\u00e1ng 4 n\u0103m 2025 \u2014 m\u1ed9t c\u1ed9t m\u1ed1c ph\u00e1p l\u00fd quan tr\u1ecdng th\u01b0\u1eddng \u0111i tr\u01b0\u1edbc c\u00e1c ph\u00ea duy\u1ec7t thu\u1ed1c th\u00e0nh c\u00f4ng. Vi\u1ec7c ph\u00ea duy\u1ec7t t\u00ean g\u1ecdi n\u00e0y cho th\u1ea5y c\u00e1c c\u01a1 quan y t\u1ebf to\u00e0n c\u1ea7u c\u00f4ng nh\u1eadn t\u1ea7m quan tr\u1ecdng ti\u1ec1m n\u0103ng c\u1ee7a li\u1ec7u ph\u00e1p trong \u0111i\u1ec1u tr\u1ecb ung th\u01b0 m\u00e1u.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)?","answer":"B\u1ea1n n\u00ean ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu NASDAQ, n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, t\u00ecm m\u00e3 \"CLLS\", \u0111\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i c\u00e1c c\u1ea3nh b\u00e1o gi\u00e1 \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu m\u1ed9t c\u00e1ch an to\u00e0n."},{"question":"C\u1ed5 phi\u1ebfu Cellectis c\u00f3 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng nh\u01b0 th\u1ebf n\u00e0o trong t\u01b0\u01a1ng lai?","answer":"D\u1ef1 b\u00e1o cho th\u1ea5y c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean 3,50-4,00 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 6-8 USD n\u0103m 2026, v\u00e0 th\u1eadm ch\u00ed l\u00ean \u0111\u1ebfn 12-15 USD v\u00e0o n\u0103m 2028 n\u1ebfu c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 ph\u00ea duy\u1ec7t th\u00e0nh c\u00f4ng."},{"question":"Nh\u1eefng r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o Cellectis l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, ti\u00eau ti\u1ec1n m\u1eb7t l\u1edbn, r\u00e0o c\u1ea3n ph\u00e1p l\u00fd, bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao v\u00e0 ph\u1ee5 thu\u1ed9c l\u1edbn v\u00e0o \u0111\u1ed1i t\u00e1c AstraZeneca."},{"question":"T\u00f4i l\u00e0 nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi, l\u00e0m sao \u0111\u1ec3 gi\u1ea3m thi\u1ec3u r\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o Cellectis?","answer":"B\u1ea1n n\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf, mua theo t\u1eebng ph\u1ea7n \u0111\u1ec3 trung b\u00ecnh gi\u00e1, \u0111\u1eb7t c\u1ea3nh b\u00e1o l\u1ee3i nhu\u1eadn v\u00e0 theo d\u00f5i c\u00e1c s\u1ef1 ki\u1ec7n l\u00e2m s\u00e0ng quan tr\u1ecdng nh\u01b0 ng\u00e0y R&D v\u00e0 b\u1eaft \u0111\u1ea7u th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 2."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 Cellectis?","answer":"Pocket Option c\u00f3 ti\u1ec1n g\u1eedi t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 giao di\u1ec7n th\u00e2n thi\u1ec7n, gi\u00fap nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi d\u1ec5 d\u00e0ng ti\u1ebfp c\u1eadn v\u00e0 th\u1ef1c h\u00e0nh \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)?","answer":"B\u1ea1n n\u00ean ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu NASDAQ, n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, t\u00ecm m\u00e3 \"CLLS\", \u0111\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i c\u00e1c c\u1ea3nh b\u00e1o gi\u00e1 \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu m\u1ed9t c\u00e1ch an to\u00e0n."},{"question":"C\u1ed5 phi\u1ebfu Cellectis c\u00f3 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng nh\u01b0 th\u1ebf n\u00e0o trong t\u01b0\u01a1ng lai?","answer":"D\u1ef1 b\u00e1o cho th\u1ea5y c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean 3,50-4,00 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 6-8 USD n\u0103m 2026, v\u00e0 th\u1eadm ch\u00ed l\u00ean \u0111\u1ebfn 12-15 USD v\u00e0o n\u0103m 2028 n\u1ebfu c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 ph\u00ea duy\u1ec7t th\u00e0nh c\u00f4ng."},{"question":"Nh\u1eefng r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o Cellectis l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, ti\u00eau ti\u1ec1n m\u1eb7t l\u1edbn, r\u00e0o c\u1ea3n ph\u00e1p l\u00fd, bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao v\u00e0 ph\u1ee5 thu\u1ed9c l\u1edbn v\u00e0o \u0111\u1ed1i t\u00e1c AstraZeneca."},{"question":"T\u00f4i l\u00e0 nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi, l\u00e0m sao \u0111\u1ec3 gi\u1ea3m thi\u1ec3u r\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o Cellectis?","answer":"B\u1ea1n n\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf, mua theo t\u1eebng ph\u1ea7n \u0111\u1ec3 trung b\u00ecnh gi\u00e1, \u0111\u1eb7t c\u1ea3nh b\u00e1o l\u1ee3i nhu\u1eadn v\u00e0 theo d\u00f5i c\u00e1c s\u1ef1 ki\u1ec7n l\u00e2m s\u00e0ng quan tr\u1ecdng nh\u01b0 ng\u00e0y R&D v\u00e0 b\u1eaft \u0111\u1ea7u th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 2."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 Cellectis?","answer":"Pocket Option c\u00f3 ti\u1ec1n g\u1eedi t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 giao di\u1ec7n th\u00e2n thi\u1ec7n, gi\u00fap nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi d\u1ec5 d\u00e0ng ti\u1ebfp c\u1eadn v\u00e0 th\u1ef1c h\u00e0nh \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T12:02:05+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)\",\"datePublished\":\"2025-08-28T12:02:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-28T12:02:05+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T12:02:05+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)","datePublished":"2025-08-28T12:02:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-28T12:02:05+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cellectis-sa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cellectis S.A. (CLLS)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":354372,"slug":"how-to-buy-cellectis-sa","post_title":"Como comprar a\u00e7\u00f5es da Cellectis S.A. (CLLS) - Investimento em a\u00e7\u00f5es da Cellectis S.A. (CLLS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-cellectis-sa\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/354374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=354374"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/354374\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=354374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=354374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=354374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}